GlassScriptPhysician profile
Scott L Dennis
NPI 1073916573
$3,736.32
in general payments reported to CMS, 2019-2025
36 companies · $1,283 in 2025
The $1,283 reported for 2025 was more than what 87% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $231 · 2022: $380 · 2023: $1,113 · 2024: $730 · 2025: $1,283.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,125.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $624.70 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $599.43 | 2022-2025 | Mounjaro, Trulicity, Zepbound |
| Abbvie INC. | $415.91 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $316.88 | 2021-2025 | Breztri, Airsupra, Farxiga |
| Glaxosmithkline, LLC. | $250.19 | 2022-2025 | Shingrix, Arexvy, Nucala |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $186.01 | 2025 | Caplyta |
| Eisai INC. | $168.38 | 2024-2025 | |
| Abbott Laboratories | $154.74 | 2022-2025 | Freestyle Libre |
| Pfizer INC. | $115.63 | 2023-2025 | |
| Novartis Pharmaceuticals Corporation | $95.42 | 2021-2025 | |
| Amgen INC. | $67.25 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $57.16 | 2021-2025 | Gardasil 9, Capvaxive, Vaxelis |
| Dexcom, INC. | $55.83 | 2022-2025 | Dexcom G6 Transmitter |
| Radius Health, INC. | $52.66 | 2025 | Tymlos |
| Alkermes, INC. | $51.95 | 2024-2025 | Aristada, Lybalvi |
Show all 36 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Dennis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.